A Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Neoplasm Metastasis
Interventions: BIOLOGICAL: CodaLytic
Sponsor: Codagenix, Inc